Survival in a consecutive series of 467 glioblastoma patients: association with prognostic factors and treatment at recurrence at two independent institutions
H Blakstad, J Brekke, MA Rahman, VS Arnesen… - PLoS …, 2023 - journals.plos.org
Therapy of recurrent glioblastoma (GBM) is challenging due to lack of standard treatment.
We investigated physicians' treatment choice at recurrence and prognostic and predictive …
We investigated physicians' treatment choice at recurrence and prognostic and predictive …
Implementing targeted therapies in the treatment of glioblastoma: previous shortcomings, future promises, and a multimodal strategy recommendation
V Fougner, B Hasselbalch, U Lassen… - Neuro-Oncology …, 2022 - academic.oup.com
The introduction of targeted therapies to the field of oncology has prolonged the survival of
several tumor types. Despite extensive research and numerous trials, similar outcomes have …
several tumor types. Despite extensive research and numerous trials, similar outcomes have …
Timing of early postoperative MRI following primary glioblastoma surgery—A retrospective study of contrast enhancements in 311 patients
AM Rykkje, VA Larsen, J Skjøth-Rasmussen… - Diagnostics, 2023 - mdpi.com
An early postoperative MRI is recommended following Glioblastoma surgery. This
retrospective, observational study aimed to investigate the timing of an early postoperative …
retrospective, observational study aimed to investigate the timing of an early postoperative …
Prognostic model for predicting overall survival in patients with glioblastoma: an analysis based on the SEER database
Y Luo, L Hao, C Liu, Y Xiang, X Han… - Journal of …, 2023 - journals.sagepub.com
Predicting the prognosis of glioblastoma (GBM) has always been important for improving
survival. An understanding of the prognostic factors for patients with GBM can help guide …
survival. An understanding of the prognostic factors for patients with GBM can help guide …
Glioblastoma: A retrospective analysis of the role of the maximal surgical resection on overall survival and progression free survival
G Polonara, D Aiudi, A Iacoangeli, A Raggi… - Biomedicines, 2023 - mdpi.com
Background: Glioblastoma (GBM) is the most common and aggressive primary brain tumor
in adults; despite advances in the understanding of GBM pathogenesis, significant …
in adults; despite advances in the understanding of GBM pathogenesis, significant …
Prognostic relevance of radiological findings on early postoperative MRI for 187 consecutive glioblastoma patients receiving standard therapy
AM Rykkje, JF Carlsen, VA Larsen… - Scientific Reports, 2024 - nature.com
Several prognostic factors are known to influence survival for patients treated with IDH-
wildtype glioblastoma, but unknown factors may remain. We aimed to investigate the …
wildtype glioblastoma, but unknown factors may remain. We aimed to investigate the …
Evidence That a Peptide-Drug/p53 Gene Complex Promotes Cognate Gene Expression and Inhibits the Viability of Glioblastoma Cells
Glioblastoma multiform (GBM) is considered the deadliest brain cancer. Conventional
therapies are followed by poor patient survival outcomes, so novel and more efficacious …
therapies are followed by poor patient survival outcomes, so novel and more efficacious …
Real-World Use of Hypofractionated Radiotherapy for Primary CNS Tumors in the Elderly, and Implications on Medicare Spending
KR Tringale, A Lin, AM Miller, A Khan, L Chen… - Journal of the National …, 2024 - jnccn.org
Background: For elderly patients with high-grade gliomas, 3-week hypofractionated
radiotherapy (HFRT) is noninferior to standard long-course radiotherapy (LCRT). We …
radiotherapy (HFRT) is noninferior to standard long-course radiotherapy (LCRT). We …
Sequential Evaluation of Hematology Markers as a Prognostic Factor in Glioblastoma Patients
JM Gonçalves, B Carvalho, R Tuna, P Polónia… - Biomedicines, 2024 - mdpi.com
In our study, we investigated the prognostic significance of hematological markers—NLR
(Neutrophil-to-Lymphocyte Ratio), PLR (Platelet-to-Lymphocyte Ratio), and RDW-CV (Red …
(Neutrophil-to-Lymphocyte Ratio), PLR (Platelet-to-Lymphocyte Ratio), and RDW-CV (Red …
Treatment of glioblastoma in Greenlandic patients
S Frandsen, AJ Pedersen, O Gredal… - … of Circumpolar Health, 2023 - Taylor & Francis
ABSTRACT Glioblastoma (GBM), WHO grade IV, is the most common primary malignant
brain tumour among adults with a devastating overall survival of 14–22 months. Standard …
brain tumour among adults with a devastating overall survival of 14–22 months. Standard …